CING
Price
$4.81
Change
+$0.06 (+1.26%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
70.09M
47 days until earnings call
Intraday BUY SELL Signals
SABS
Price
$2.98
Change
-$0.08 (-2.61%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
292.52M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CING vs SABS

CING vs SABS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CING vs. SABS commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a Hold and SABS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
CINGSABS
RSI
ODDS (%)
Bearish Trend 5 days ago
79%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (CING: $4.75 vs. SABS: $3.06)
Brand notoriety: CING and SABS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 30% vs. SABS: 94%
Market capitalization -- CING: $70.09M vs. SABS: $292.52M
CING [@Biotechnology] is valued at $70.09M. SABS’s [@Biotechnology] market capitalization is $292.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 1 FA rating(s) are green while SABS’s FA Score has 0 green FA rating(s).

  • CING’s FA Score: 1 green, 4 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, CING is a better buy in the long-term than SABS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 3 TA indicator(s) are bullish while SABS’s TA Score has 4 bullish TA indicator(s).

  • CING’s TA Score: 3 bullish, 7 bearish.
  • SABS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SABS is a better buy in the short-term than CING.

Price Growth

CING (@Biotechnology) experienced а -6.13% price change this week, while SABS (@Biotechnology) price change was -8.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

CING is expected to report earnings on Nov 18, 2026.

SABS is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CING
Daily Signal:
Gain/Loss:
SABS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AUGP34.010.01
+0.03%
PGIM S&P 500 Buffer 12 ETF - August (AUGP)
IQSM38.44N/A
N/A
NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM)
ILS20.14-0.02
-0.10%
Brookmont Catastrophic Bond ETF
DVDN13.79-0.08
-0.60%
Kingsbarn Dividend Opportunity ETF (DVDN)
DGS62.41-0.77
-1.22%
WisdomTree Emerging Markets SmallCap Dividend Fund (DGS)

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with CTMX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then CTMX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-4.04%
CTMX - CING
35%
Loosely correlated
-3.31%
ELVN - CING
29%
Poorly correlated
+0.81%
PLX - CING
28%
Poorly correlated
-2.90%
TGTX - CING
27%
Poorly correlated
-3.87%
SABS - CING
27%
Poorly correlated
-3.47%
More

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
-3.47%
REVB - SABS
48%
Loosely correlated
-1.96%
INKT - SABS
47%
Loosely correlated
+1.43%
CYPH - SABS
46%
Loosely correlated
-12.31%
TECX - SABS
35%
Loosely correlated
-2.66%
RANI - SABS
34%
Loosely correlated
+0.57%
More